5-Amino 1MQ (5-Amino-1-Methylquinolinium) NNMT Inhibitor 5mg Peptide Vial

$55.00

In stock (can be backordered)

Title Range Discount
Quantity Discount 3 - 5 8%
Quantity Discount 6 - 9 13%
Quantity Discount 10 + 18%

Description

Product Overview:

5-Amino-1MQ (5-Amino-1-Methylquinolinium) is a small-molecule research compound studied primarily for its activity as an inhibitor of nicotinamide N-methyltransferase (NNMT), an intracellular enzyme involved in methylation balance, nicotinamide metabolism, and cellular energy regulation.

NNMT has become a growing area of interest in metabolic and adipocyte biology due to its role in regulating pathways associated with:

  • Cellular energy expenditure
  • NAD+ precursor utilization
  • Methyl donor metabolism (SAM-dependent pathways)
  • Adipocyte function and lipid storage signaling
  • Metabolic efficiency in preclinical models

By inhibiting NNMT activity, 5-Amino-1MQ has been investigated in experimental systems for its effects on intracellular metabolism and fat-cell biology.

The compound offered by Proliven Labs is supplied as high-purity (≥99.5%) lyophilized powder, manufactured for reproducibility in controlled research settings.

Common research areas include:

  • NNMT inhibition studies
  • Adipocyte metabolism models
  • Cellular NAD+ pathway research
  • Energy expenditure signaling studies
  • Obesity and metabolic dysfunction models

Each vial contains 5mg of lyophilized 5-Amino-1MQ, verified through batch-specific analytical testing.

Strictly for Research Use Only (RUO). Not for human or veterinary use.

Peptide Specifications:

Chemical Name:
5-Amino-1-Methylquinolinium

Synonyms:
5-Amino-1MQ
NNMT Inhibitor

CAS Number:
104819-66-9 (verify with supplier COA before publication)

Molecular Formula:
C₁₀H₁₁N₂⁺

Molecular Weight:
159.21 g/mol

Purity:
≥99.5% (HPLC verified)

Form:
Lyophilized powder

Quantity:
5mg per vial

Appearance:
Off-white to pale yellow powde

Solubility

Soluble in aqueous laboratory solvents and buffered systems appropriate for experimental design.

Suitable solvents may include:

  • Sterile water
  • Buffered aqueous solutions
  • DMSO (where applicable for in vitro systems)

Storage Conditions

Short-term:
2–8°C

Long-term:
-20°C or below

Protect from:

  • Moisture
  • Heat
  • Light

Analytical Verification

Each batch undergoes:

  • HPLC purity verification
  • Mass spectrometry identity confirmation
  • Batch traceability documentation

Research Applications

NNMT Inhibition Research

5-Amino-1MQ is widely studied as a tool compound for evaluating NNMT activity in metabolic systems.


Adipocyte Biology Models

Used in experimental models examining:

  • Fat-cell metabolism
  • Lipid accumulation signaling
  • Cellular energy expenditure pathways

NAD+ Metabolism Research

Because NNMT intersects with nicotinamide utilization pathways, 5-Amino-1MQ is frequently investigated in studies related to:

  • NAD+ precursor dynamics
  • Cellular redox regulation
  • Energy metabolism

Methylation Pathway Research

NNMT consumes methyl donors, making this compound useful in:

  • SAM/SAH pathway research
  • Cellular methylation balance studies
  • Metabolic signaling investigations

Obesity & Metabolic Dysfunction Models

Preclinical research has explored 5-Amino-1MQ in models involving:

  • Adiposity
  • Weight regulation
  • Metabolic efficiency

Mechanisms of Action

Selective NNMT Inhibition

5-Amino-1MQ inhibits nicotinamide N-methyltransferase (NNMT).

NNMT normally catalyzes:

Nicotinamide + SAM → 1-Methylnicotinamide + SAH

By inhibiting this pathway, 5-Amino-1MQ alters metabolic signaling relevant to:

  • Energy expenditure
  • Nicotinamide utilization
  • Methyl donor conservation

Adipocyte Metabolic Effects

Experimental models suggest NNMT inhibition may influence:

  • Fat-cell energy utilization
  • Lipid storage signaling
  • Cellular metabolic efficiency

NAD+ Pathway Relevance

Research suggests indirect effects on pathways related to:

  • Nicotinamide salvage
  • NAD+ precursor availability
  • Mitochondrial metabolic signaling

Preclinical Research Data

Murine Adiposity Models

Preclinical studies evaluating NNMT inhibition have reported effects involving:

  • Reduced fat mass accumulation
  • Altered adipocyte metabolism
  • Increased energy expenditure markers

Experimental outcomes vary by:

  • Dose
  • Duration
  • Model system
  • Route of administration

Cellular Models

In vitro studies have demonstrated:

  • Target engagement at NNMT
  • Metabolic pathway modulation
  • Altered adipocyte signaling profiles

Reconstitution & Handling

Reconstitution

5-Amino-1MQ is supplied as lyophilized powder.

Typical research reconstitution:

  • 1–3 mL sterile solvent
  • Swirl gently
  • Do not shake

Post-Reconstitution Storage

Store reconstituted material at:

2–8°C

Use according to study-specific stability requirements.

Avoid repeated freeze-thaw cycles.


Research Protocols & Dosing Considerations

Research involving 5-Amino-1MQ varies substantially by model.

In Vitro Studies

Variables commonly adjusted:

  • Concentration
  • Exposure duration
  • Cell type
  • Endpoint measurements

Preclinical Studies

Variables commonly adjusted:

  • Dose
  • Delivery route
  • Study duration
  • Experimental objective

Appropriate controls should be used to isolate compound-specific effects.

Research Protocols & Considerations

Research involving 5-Amino-1MQ varies significantly depending on experimental design, model system, and study objectives.

In Vitro Research

5-Amino-1MQ is commonly utilized in cell-based systems investigating:

  • NNMT inhibition kinetics
  • Adipocyte metabolism and lipid signaling
  • Nicotinamide pathway modulation
  • Cellular methylation dynamics (SAM-dependent pathways)
  • Metabolic stress and mitochondrial function models

Typical experimental variables may include:

  • Cell type (e.g. adipocytes, hepatocytes, metabolic cell lines)
  • Exposure duration
  • Compound concentration
  • Target engagement endpoints
  • Metabolic biomarker measurements

Preclinical Models

In animal research, 5-Amino-1MQ has been studied in models involving:

  • Adiposity and body composition research
  • Energy expenditure models
  • Metabolic dysfunction investigations
  • NNMT pathway modulation studies

Experimental parameters vary based on:

  • Route of administration
  • Dose selection
  • Study duration
  • Tissue targets
  • Experimental endpoints

General Research Considerations

Researchers should consider:

  • Concentration-dependent effects, which may vary by model system
  • Target engagement verification, particularly in NNMT pathway studies
  • Solubility and stability considerations during study design
  • Appropriate controls to isolate compound-specific effects
  • Potential interactions with methylation or NAD+-related pathways when used alongside other metabolic research compounds

Important

This product is intended strictly for Research Use Only (RUO) and is not intended for human or veterinary use.

Safety & Regulatory Notes

Research Use Only (RUO)

This product is intended exclusively for laboratory research applications.

It is not intended for:

  • Human use
  • Veterinary use
  • Diagnostic use
  • Therapeutic use
  • Clinical administration

Safety Profile

Safety data for 5-Amino-1MQ is derived primarily from:

  • In vitro research
  • Preclinical animal studies
  • Experimental metabolic pathway investigations

Safety outcomes may depend on:

  • Experimental concentration
  • Exposure duration
  • Model system
  • Route of administration in preclinical studies

No established safety profile exists for clinical or non-research use.


Handling Precautions

Use appropriate laboratory PPE, including:

  • Gloves
  • Eye protection
  • Protective laboratory attire

Avoid:

  • Inhalation
  • Ingestion
  • Direct skin or eye exposure

Use standard laboratory handling protocols.


Regulatory Status

5-Amino-1MQ is:

  • Not approved by the U.S. FDA for therapeutic use
  • Not approved for diagnosis or treatment of disease
  • Not approved for human consumption
  • Intended solely as a research compound

Researchers are responsible for compliance with all applicable regulations governing handling and use.

Quality Assurance

Each batch of 5-Amino-1MQ undergoes analytical testing to help ensure identity, purity, and batch consistency.

Testing Includes

  • High-Performance Liquid Chromatography (HPLC)
    • Purity verification (≥98%)
  • Mass Spectrometry (MS)
    • Molecular identity confirmation

Contaminant Screening

Batch testing may include screening for:

  • Heavy metals
  • Residual solvents (where applicable)
  • Microbial impurities
  • Synthesis-related contaminants

Certificate of Analysis (COA)

Batch-specific Certificate of Analysis (COA) available for:

  • Identity confirmation
  • Purity data
  • Analytical testing results
  • Batch traceability

COA Lookup Available → [Insert COA Lookup Link]


Manufacturing Standards

Produced under controlled synthesis conditions to support:

  • Batch consistency
  • Stability
  • Reproducibility in research environments

Batch Traceability

Each vial includes a unique batch number to support:

  • Quality tracking
  • Analytical verification
  • Lot-specific traceability

Disclaimer:

This product is intended strictly for research use only (RUO).

It is not intended for human or veterinary use and is not approved for:

  • Diagnosis
  • Treatment
  • Cure
  • Prevention of any disease

By purchasing this product, the user acknowledges that:

  • The material will be used solely for laboratory research
  • The user is qualified to handle research chemicals
  • All use complies with applicable regulations

The purchaser assumes full responsibility for proper handling, storage, and use.

Additional information

Weight 0.25 lbs
Dimensions 12.25 × 10.9 × 1.5 in

Reviews

There are no reviews yet.

Be the first to review “5-Amino 1MQ (5-Amino-1-Methylquinolinium) NNMT Inhibitor 5mg Peptide Vial”

Your email address will not be published. Required fields are marked *